Clinical Trial Update: Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cetuximab plus best supportive care versus best supportive care alone in metastatic EGFR-positive colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Colorectal Cancer, Quality of Life | Phase 3 | Status: COMPLETED